摘要
左主干病变(Left main coronary artery, LMCA)是指冠状动脉左主干直径狭窄大于50%的病变。作为冠状动脉病变中死亡率最高的疾病,LMCA一直是冠状动脉疾病治疗中的重点与难点。长期以来,冠状动脉旁路移植术(Coronary artery bypass graft, CABG)是治疗左主干病变的首选方案。近年来,随着冠脉内成像技术的进步,经皮冠状动脉介入治疗术(Percutaneous coronary intervention, PCI)在左主干病变的治疗中占据一席之地。本文就国内外在左主干病变评估及治疗方面取得的进展做一综述。
Left main coronary artery (LMCA) was defined as a coronary artery with a stenosis greater than 50% in diameter. As the disease with the highest mortality rate in coronary artery disease, LMCA has always been the focus and difficulty in the treatment of coronary artery disease. Coronary artery bypass graft (CABG) has long been the first choice for the treatment of left main artery disease. In recent years, with the development of coronary imaging technology, percutaneous coronary inter-vention (PCI) occupies a place in the treatment of left main artery disease. This article reviews the progress in the evaluation and treatment of left main disease.
出处
《临床医学进展》
2022年第8期7385-7392,共8页
Advances in Clinical Medicine
